Publications by authors named "Hoeger P"

Article Synopsis
  • This project gathered experts to create guidelines for treating a skin condition called pediatric Mycosis fungoides (MF), which is different from how adults are treated.
  • They talked about important factors that go beyond just measuring the size of the disease, like itching, how it affects daily life, and feelings of worry or embarrassment.
  • The team made 10 recommendations for managing both early and advanced stages of pediatric MF, but they still need more information on how to treat the later stages properly.
View Article and Find Full Text PDF

Background: Leukocyte adhesion deficiency type 1 (LAD-1) is a congenital immunodeficiency leading to impaired trafficking of neutrophils to inflammation sites. Solitary or multiple pyoderma gangrenosum (PG)-like skin ulcers (PGLUs) have been reported previously in 13 children (aged 0.5-19 years) with LAD-1.

View Article and Find Full Text PDF

The purported antiviral effect of dupilumab may be considered a positive side effect. Its mechanism, however, points to an underlying immunomodulation with potentially far-reaching consequences.

View Article and Find Full Text PDF

Background: Short anagen hair (SAH) is a rare paediatric hair disorder characterized by a short anagen phase, an inability to grow long scalp hair and a negative psychological impact. The genetic basis of SAH is currently unknown.

Objectives: To perform molecular genetic investigations in 48 individuals with a clinical phenotype suggestive of SAH to identify, if any, the genetic basis of this condition.

View Article and Find Full Text PDF

Marie Unna hereditary hypotrichosis (MUHH) is a rare autosomal dominant hair loss disorder characterized by coarse, wiry, and twisted hair developing during early childhood, and followed by progressive hair loss with puberty. We report a sporadic case of a 4-year-old boy with clinical features suggestive of MUHH, in whom we identified the new pathogenic variant c.67C>T; p.

View Article and Find Full Text PDF
Article Synopsis
  • Epidermolysis bullosa (EB) is a rare genetic skin disorder causing blisters to form on the skin and mucous membranes, with varying severity among patients.
  • A study conducted in Germany found an EB incidence of 45 cases per million live births, with higher rates for junctional EB compared to other countries, possibly due to better early genetic diagnosis.
  • With estimates of around 2000 EB patients in Germany, the findings aim to influence healthcare policies, drug development strategies, and support patient advocacy efforts for improved quality of life.
View Article and Find Full Text PDF

Hereditary fibrosing poikiloderma with tendon contractures, myopathy, and pulmonary fibrosis (POIKTMP) is a genodermatosis with autosomal dominant inheritance caused by mutations in FAM111B. We report another case with a new pathogenic variant and analyze all previously published 34 cases with a focus on sequence of clinical presentation and genotype-phenotype correlation. POIKTMP is characterized by marked age-dependent clinical expressivity.

View Article and Find Full Text PDF

We report the case of a 4-year-old boy, post-human stem cell transplantation for severe combined immunodeficiency (SCID) due to adenosine deaminase deficiency (ADA), who developed multiple dermatofibrosarcoma protuberans (DFSP). We hypothesize a role for chimerism leading to accumulation of toxic metabolites which can cause DNA strand breaks and inhibit lymphocyte activation. Patients with ADA-SCID should remain under lifelong dermatologic surveillance as DFSP lesions can be quite inconspicuous.

View Article and Find Full Text PDF

Blue rubber bleb nevus syndrome is a rare vascular syndrome characterized by continuous eruption of vascular nodules in the skin, mucous membranes, and solid organs due to somatic activating mutations of the angiopoietin receptor TEK gene. It may be complicated by acute life-threatening hemorrhage and localized intravascular coagulation. We report an 11-year-old girl with complicated blue rubber bleb nevus syndrome treated with sirolimus since the age of 2.

View Article and Find Full Text PDF

Vascular malformations (VMs) are caused by localized defects of vascular development. Most VMs are due to sporadic, postzygotic mutations, while some are the result of autosomal dominant germline mutations. Genotype-phenotype correlation is influenced by many factors.

View Article and Find Full Text PDF
Article Synopsis
  • - A study examined how neuraminidase inhibitors (NAIs) affect the length of hospital stays for patients with influenza A(H1N1)pdm09 by analyzing data from over 18,000 individuals from 70 clinical centers.
  • - Results indicated that starting NAI treatment upon hospitalization leads to a 19% decrease in length of stay compared to starting later or not at all, with consistent findings across different patient groups.
  • - The study concluded that immediate NAI treatment for hospitalized influenza patients correlates with shorter hospital stays compared to delayed treatment or no treatment, regardless of when symptoms began.
View Article and Find Full Text PDF
Article Synopsis
  • - Adalimumab (ADA), approved for children ages 4 and up with severe plaque psoriasis, was evaluated for its long-term effectiveness and safety in this patient group over a 52-week study.
  • - The study involved 114 patients, of which 108 continued into the long-term extension, with varying dosages of ADA and methotrexate being administered, showing a significant improvement in psoriasis severity.
  • - Results indicated that patients maintained or improved their condition after one year of ADA treatment, with no serious infections reported, confirming the drug's safety for long-term use in this demographic.
View Article and Find Full Text PDF

Background: The proliferative phase of infantile hemangiomas (IHs) is usually complete by 9 months of life. Late growth beyond age 3 years is rarely reported.

Objective: To describe the demographic and clinic characteristics of a cohort of patients with late growth of IH, defined as growth in a patient >3 years of age.

View Article and Find Full Text PDF

Bone involvement is relatively rare in vascular malformations. Gorham-Stout disease, also referred to as , is characterized by osteoclast activation and osteolysis caused by proliferating lymphatic endothelial cells. We present the case of a 12-year-old boy who had Gorham-Stout disease at the age of 8 years.

View Article and Find Full Text PDF

Background: Adalimumab is indicated for the treatment of moderate to severe psoriasis in adults. We assessed the efficacy and safety of adalimumab in children and adolescents with severe plaque psoriasis.

Methods: This randomised, double-blind, multiperiod, phase 3 trial was done at 38 clinics in 13 countries.

View Article and Find Full Text PDF

With a prevalence of 4·5%, infantile haemangiomas are the most common benign tumours of infancy, arising in the first few weeks of life and exhibiting a characteristic sequence of growth and spontaneous involution. Most infantile haemangiomas do not require therapy. However, to identify at-risk haemangiomas, close follow-up is crucial in the first weeks of life; 80% of all haemangiomas reach their final size by 3 months of age.

View Article and Find Full Text PDF

Objectives: To develop recommendations for investigation and monitoring of children with Raynaud's syndrome, based on paediatric evidence collated by a systematic review.

Methods: A systematic review was undertaken to establish the paediatric evidence for assessment and monitoring of Raynaud's syndrome. An expert panel including members of the Paediatric Rheumatology European Society (PRES) Scleroderma Working Group, were invited to a consensus meeting where recommendations were developed based on evidence graded by the systematic review and where evidence was lacking, consensus opinion.

View Article and Find Full Text PDF

Background/objectives: Multifocal infantile hemangiomas (MIHs; previously called neonatal hemangiomatosis) can be associated with extracutaneous hemangiomas. We observed different morphologic types of hemangiomas in children with MIHs and sought to find out whether they are related to the clinical course.

Methods: This was a retrospective study of 103 infants with MIHs and a control group of 261 age-matched patients with solitary focal infantile hemangiomas (IHs) seen at an academic pediatric dermatology department between 2004 and 2014.

View Article and Find Full Text PDF

Background: From 18% to 30% of infantile hemangiomas (IH) are located on the extremities (IHE). They can be divided into localized, segmental, and minimal or arrested growth (IH-MAG) subtypes.

Objective: We sought to correlate localization of IHE with the anatomy of the arterial vascular supply.

View Article and Find Full Text PDF